LONDON — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was
In a statement, the university confirmed the restart across all of its U.K. clinical trial sites after regulators gave the go-ahead following the pause on Sunday.
The university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.” The university insisted that it is “committed to the safety of our participants and the highest standards of conduct in our studies and will continue to monitor safety closely.”
Because of their large size, the studies are considered the most important study phase for picking up less common side effects and establishing safety.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca's Oxford vaccine trial to resume, the university saysThe AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced.
Read more »
Major COVID-19 vaccine trial resumes in UK after safety review'Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.'
Read more »
AstraZeneca's Oxford vaccine trial to resume, the university saysThe AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced.
Read more »
Vaccine trial stopped after neurological symptoms detectedLONDON — A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said
Read more »
Vaccine trial stopped after neurological symptoms detectedLONDON — A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said
Read more »